Understanding Your Child's Imerslund-Gräsbeck Syndrome Diagnosis

Finally having a name for the symptoms your child has been experiencing—such as extreme fatigue, pale skin, or poor weight gain (often called “failure to thrive” in medical reports)—often brings a complex mix of emotions. You may feel a profound sense of relief that the period of medical uncertainty is over, paired with the natural anxiety of learning your child has a rare genetic condition ^[1][2]. It is common for parents to have spent months or even years searching for answers, sometimes seeing multiple specialists before Imerslund-Gräsbeck syndrome (IGS) was identified ^[3][4].

While the condition is exceptionally rare—with fewer than several hundred cases reported in the medical literature worldwide ^[5]—the path forward is defined. Because it is so rare, your local pediatrician may never have seen a case before, but specialists understand generally why it happens and how to manage it.

What is Imerslund-Gräsbeck Syndrome?

IGS is a genetic condition that affects how your child’s body handles two very different tasks: absorbing Vitamin B12 and keeping protein in the blood. Under normal circumstances, a receptor complex in the small intestine (made of two parts called cubilin and amnionless) is responsible for absorbing Vitamin B12 from food ^[6]. In children with IGS, this receptor does not work correctly because of a change in their DNA ^[7].

This leads to two main features:

1. Selective Vitamin B12 Malabsorption: Your child can eat plenty of B12, but their body cannot move it from the gut into the bloodstream ^[8]. Vitamin B12 is essential for making healthy red blood cells and maintaining the protective coating around nerves. Without it, children develop megaloblastic anemia (where red blood cells are too large and do not work well) and may eventually experience neurologic issues like weakness or developmental delays ^[9][4].
2. Proteinuria: The same receptor complex is also used by the kidneys to pull filtered protein back into the body before it can be lost in the urine ^[6]. In IGS, some protein is lost when the child urinates. While this proteinuria is a hallmark of the disease, it often does not cause immediate symptoms, though doctors will monitor it closely ^[10][11].

How Your Child Inherited IGS

IGS is an autosomal recessive condition. This means that for a child to have IGS, they must inherit two copies of a non-working gene—one from each parent ^[8]. Neither parent did anything to cause this condition.

• Carriers: Parents are typically “carriers,” meaning you have one working copy of the gene and one non-working copy. Carriers usually have no IGS-related symptoms or deficiency, and usually have no idea they carry the gene until they have an affected child ^[12].
• The 25% Chance: When both parents are carriers, there is a 25% (1 in 4) chance with each pregnancy that the child will inherit both non-working copies and have IGS ^[11].

Because IGS is genetic, doctors often recommend targeted familial-variant testing for siblings through a genetics team.

The Road Ahead: Effective Treatment

The most important thing to know on day one is that IGS is highly treatable. While the body cannot absorb B12 through the digestive tract, it can use Vitamin B12 perfectly well if it is delivered another way—usually through an injection into the muscle or under the skin (parenteral therapy) ^[13][11]. Do not delay starting treatment while waiting for genetic test results.

Once treatment begins, recovery usually starts quickly:

• Rapid Improvement: The fatigue and anemia typically begin to resolve quickly once B12 levels are restored ^[14][9]. Neurological symptoms also begin to improve, though the extent of recovery varies depending on how long the deficiency was present.
• Lifelong Management: Because the genetic cause does not change, your child will likely need B12 injections for the rest of their life ^[11].
• Monitoring the Kidneys: While the anemia usually goes away with treatment, the protein in the urine often persists ^[10]. This is a unique feature of IGS and usually does not mean the treatment isn’t working; it just means the kidney portion of the receptor is still affected ^[8].